News & Updates

In the TANGO* trial, a Mediterranean-like, culturally contextualized Asian diet rich in fibre and unsaturated fatty acids, induced multiple health benefits in Chinese women with nonalcoholic fatty liver disease (NAFLD), including weight loss.

Individuals with nonalcoholic fatty liver disease (NAFLD) may face stigma from the disease or comorbidities, but the perceptions of shame differ across patients, healthcare providers, geographic locations, and subspecialties, reveals a study.

Omalizumab scores in the NIH*-sponsored phase III OUtMATCH** trial, increasing the threshold for an allergic reaction to peanut and other common food allergens in children and adults with multiple food allergies.